Understanding Corticosteroid-Related Medical-Legal Risks in Inflammatory Dermatoses

In this episode, “Understanding Corticosteroid-Related Medical-Legal Risks in Inflammatory Dermatoses,” the expert faculty explore the consensus statement addressing the medical-legal considerations associated with corticosteroid prescribing and the importance of responsible corticosteroid stewardship in clinical practice. The panel discusses how growing awareness of corticosteroid-related adverse events has implications not only for patient safety, but also for clinician accountability and risk management.

Throughout the discussion, the faculty review evidence demonstrating that corticosteroid-related adverse events have been the subject of malpractice claims and legal cases involving dermatologists. While emphasizing that corticosteroids remain important therapeutic tools, the panel highlights the need for clinicians to maintain awareness of the potential risks associated with both topical and systemic corticosteroid use. Faculty members discuss how thoughtful prescribing practices, patient counseling, and ongoing monitoring can help optimize outcomes while minimizing unnecessary risk.

The conversation also focuses on the practical challenges of monitoring corticosteroid exposure in real-world practice. The panel examines the difficulty of quantifying cumulative steroid burden when patients may receive corticosteroids from multiple healthcare providers, including pulmonologists, rheumatologists, orthopedic specialists, and primary care clinicians. Expert faculty share strategies for assessing total corticosteroid exposure, obtaining accurate medication histories, and identifying patients who may be at risk for excessive cumulative use. In addition, the panel discusses practical prescribing considerations, including refill management, appropriate medication quantities, and the importance of balancing adequate treatment with avoiding overuse. Ultimately, the discussion reinforces the concept of corticosteroid stewardship, emphasizing that careful monitoring, individualized treatment planning, and ongoing patient engagement are essential components of long-term management in inflammatory dermatoses.

The next episode in this series, “The Safety of Advanced Topical Therapies in Inflammatory Dermatoses,” features the panelists examining the efficacy of advanced targeted topical therapies and their role in achieving durable disease control. The faculty discuss how proactive, steroid-sparing treatment strategies may help reduce disease flares and support long-term management of inflammatory dermatoses.